Medical Oncology

Vision Statement

To emerge as a leader in oncology education, research, and patient-centred care by integrating evidence-based practice, cutting-edge innovation, and compassionate service.

The Department of Medical Oncology at AIIMS Bilaspur envisions building a multidisciplinary workforce equipped to address India’s growing cancer burden, nurturing future leaders in Oncology, advancing cancer research, and strengthening oncology services across both tertiary and district-level care.

Through ethical integration of technology, global collaborations, and community-focused initiatives, the department strives to transform cancer care delivery and training in the region and beyond.

Mission Statement

Our mission is to deliver comprehensive, compassionate, and evidence-based cancer care while advancing oncology education and research.

We are committed to training the next generation of healthcare professionals through structured, guideline-aligned curricula; fostering innovation in rare cancer research; and integrating ethical use of technology to enhance patient outcomes.

By collaborating across disciplines and engaging with the community, the Department of Medical Oncology at AIIMS Bilaspur strives to reduce the cancer burden in India and set new benchmarks in tertiary and regional oncology services.

Faculty

S. No. Photo Name and Qualification Designation Area of Interest Email ID / ResearchGate Page
1 Dr Pravesh Dhiman Dr. Pravesh Dhiman
(MD, DrNB)		 Additional Professor and Head Multiple Myeloma, Chronic Leukemia, NHL, Lung, Breast and Ovarian Cancers ORCID iD:
0000-0002-2490-6240 
2 Dr Mridul Khanna Dr. Mridul Khanna
(MD, DM)		 Assistant Professor A community-oriented medical oncologist dedicated to improving cancer outcomes by optimizing access to modern systemic therapies across tumor types, with a special interest in adult solid tumors. dr.mridul.oncology@aiimsbilaspur.edu.in

Services

In-Patients Department:

The Department of Medical Oncology provides comprehensive inpatient care for patients requiring intensive monitoring and management.

Services include administration of systemic therapies such as chemotherapy, targeted therapy, and immunotherapy; management of treatment-related toxicities; supportive and palliative care; and coordination of multidisciplinary care for complex oncological cases.

Dedicated care is provided for oncological emergencies including febrile neutropenia, tumor lysis syndrome, and disease-related complications.

The department works in close collaboration with other specialties to ensure holistic patient management.

Outpatients Department:

The Outpatient Department (OPD) serves as the primary point of contact for cancer patients and offers comprehensive evaluation, treatment planning, and follow-up care.

Services include initial consultation, staging workup, treatment decision-making, administration of day-care therapies, and long-term surveillance.

A strong emphasis is placed on multidisciplinary discussions to ensure individualized, evidence-based treatment plans. Preventive oncology, patient counseling, and survivorship care are also integral components of OPD services.

Procedures (Diagnostic and Therapeutic) Offered by the Department:

  • Bone marrow aspiration and biopsy.
  • Lumbar puncture with intrathecal chemotherapy administration.
  • Ascitic and pleural fluid tapping (therapeutic and diagnostic).
  • Central venous access device management (where applicable).
  • Administration of chemotherapy, targeted therapy, and immunotherapy in day-care and inpatient settings.

All procedures are performed following standard safety protocols to ensure patient comfort and quality care.

Statistics Courses & Short Term Trainings

S. No. Name of the Course Curriculum Duration of Course Present Number of Students Objectives / Brief Description of Course
1 DM Medical Oncology 3 Academic Years No Superspeciality course in Medical Oncology.

Research

S. No. Title Principal Investigator Co-Investigator Collaboration if any (Department / Institute) Funding Agency Project Status
1 Financial Toxicity of Anticancer Drugs and Its Implications on Health Care Delivery and Quality of Life of Cancer Patients Co-PI - - Non-Funded (Institutional) Completed
2 Hospital-Based Cancer Registries in India (As Site Co-PI)

Project ID: NCDIR/HBCR/12/NF/100/2022/5799		 Site Co-PI ICMR-NCDIR, Bengaluru - ICMR-NCDIR, Bengaluru
Non-Funded		 Ongoing
3 A Single-Arm Clinical Trial to Investigate the Efficacy and Safety of Palbociclib as an Add-On Drug to Oral Metronomic Therapy in Recurrent / Relapsed / Refractory Head and Neck Squamous Cell Cancer Patients PI - AIIMS Bilaspur Approved for Funding Ongoing


 

ISRAC Approved Projects

  1. Potentiality of LAMP3 and NRP1 as predictive biomarkers for anti-PD-1 therapy response in lung and head and neck cancers and elucidation of the signaling cascade associated with therapy resistance in terminally exhausted T cells to design new targeting strategies.
  2. Survival Determinants in Oligometastatic Lung Carcinoma: An Ambispective Study.
  3. Patient Reported Outcomes with Various Dosage Forms of Megestrol Acetate in Patients with Cancer Cachexia (PROMMACC).

Projects

Title Principal Investigator Co-Investigator Collaboration if any (Department / Institute) Funding Agency Project Status
Details will be updated soon.

Expansion Plan

S. No. Collaboration For Collaboration with Department / Institute Services Offered / Work Undergoing in Collaboration
Details will be updated soon.